Evidence map›Paper›PMID 36016607›Full record

ArticleFrontiers in oncology2022

Identifying cancer tissue-of-origin by a novel machine learning method based on expression quantitative trait loci.

Yongchang Miao, Xueliang Zhang, Sijie Chen, Wenjing Zhou, Dalai Xu, Xiaoli Shi, Jian Li, Jinhui Tu, Xuelian Yuan, Kebo Lv and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Yongchang MiaoGastroenterology Center, The Second People's Hospital of Lianyungang, Lianyungang, China.
Xueliang ZhangFifth Division of Cancer, Jiamusi Cancer Hospital, Jiamusi, China.
Sijie ChenDepartment of Mathematics, Ocean University of China, Qingdao, China.
Wenjing ZhouDepartment of Oncology, Hiser Medical Center of Qingdao, Qingdao, China.
Dalai XuGastrointestinal Surgery, The Second People's Hospital of Lianyungang, Lianyungang, China.
Xiaoli ShiDepartment of Science, Geneis Beijing Co., Ltd., Beijing, China.
Jian LiDepartment of Mathematics, Ocean University of China, Qingdao, China.
Jinhui TuDepartment of Mathematics, Ocean University of China, Qingdao, China.
Xuelian YuanDepartment of Science, Geneis Beijing Co., Ltd., Beijing, China.
Kebo LvDepartment of Mathematics, Ocean University of China, Qingdao, China.
Geng TianDepartment of Science, Geneis Beijing Co., Ltd., Beijing, China.
Ocean University of China · CNJiamusi University · CNQingdao Center of Resource Chemistry and New Materials · CNThe First People’s Hospital of Lianyungang · CNXian Yang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer of unknown primary (CUP) refers to cancer with primary lesion unidentifiable by regular pathological and clinical diagnostic methods. This kind of cancer is extremely difficult to treat, and patients with CUP usually have a very short survival time. Recent studies have suggested that cancer treatment targeting primary lesion will significantly improve the survival of CUP patients. Thus, it is critical to develop accurate yet fast methods to infer the tissue-of-origin (TOO) of CUP. In the past years, there are a few computational methods to infer TOO based on single omics data like gene expression, methylation, somatic mutation, and so on. However, the metastasis of tumor involves the interaction of multiple levels of biological molecules. In this study, we developed a novel computational method to predict TOO of CUP patients by explicitly integrating expression quantitative trait loci (eQTL) into an XGBoost classification model. We trained our model with The Cancer Genome Atlas (TCGA) data involving over 7,000 samples across 20 types of solid tumors. In the 10-fold cross-validation, the prediction accuracy of the model with eQTL was over 0.96, better than that without eQTL. In addition, we also tested our model in an independent data downloaded from Gene Expression Omnibus (GEO) consisting of 87 samples across 4 cancer types. The model also achieved an f1-score of 0.7-1 depending on different cancer types. In summary, eQTL was an important information in inferring cancer TOO and the model might be applied in clinical routine test for CUP patients in the future.

Indexed as

cancer of unknown primaryexpression quantitative trait lociGEOTCGAtissue-of-originXGBoost

Identifiers

PMID36016607
PMCPMC9396384
OpenAlexW4292454761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.